Clinical Trials Browser

Phase 2 × Depsipeptides × Plasma cell × Clear all

NCT00765102 2019-11-25

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Phase 2 Terminated

32 enrolled 14 charts

Multiple Myeloma